{"result": ["SECOND-LINE", "MEASURABLE METASTATIC BREAST CANCER", "PERFORMANCE STATUS", "STABLE DISEASE", "PARTIAL REMISSION", "COMBINATION CHEMOTHERAPY", "METASTATIC DISEASE", "COMPLETE REMISSION", "FIRST-LINE TREATMENT", "OBJECTIVE REMISSION RATE", "SIGNIFICANT DIFFERENCE", "FEC", "REMISSION DURATION", "SINGLE-AGENT TREATMENT ARM", "DISEASE PROGRESSION", "FIRST-LINE SINGLE-AGENT MITOXANTRONE", "HIGH-RISK METASTATIC BREAST CANCER", "SINGLE-AGENT MITOXANTRONE TREATMENT ARM", "FIRST-LINE COMBINATION CHEMOTHERAPY", "HIGH-RISK METASTATIC BREAST CANCER PATIENTS", "BRUNNER", "HIGH-RISK CRITERIA", "SINGLE-AGENT TREATMENT", "TREATMENT BENEFIT", "POTENTIAL SMALL PROLONGATION", "FINAL EVALUATION", "OVERALL SURVIVAL", "LIFE SCORE", "COMBINATION TREATMENT"]}